Bromide

Bromide

SCHEMBL466201

CCCCCCCCCC[n+]1ccn(C)c1.[Br-]

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 1/20 0.52
CHRM4 known ✓ P08173 1/20 0.52
CHRM5 known ✓ P08912 1/20 0.52
CHRM1 known ✓ P11229 1/20 0.52
CHRM3 known ✓ P20309 1/20 0.52
ACHE known ✓ P22303 1/20 0.52
HSP90AA1 P07900 2/20 0.52
RAD52 P43351 2/20 0.52
EGFR P00533 1/20 0.52
LMNA P02545 1/20 0.52
PLA2G1B P04054 1/20 0.52
ERBB2 P04626 1/20 0.52
LCK P06239 1/20 0.52
FYN P06241 1/20 0.52
ADRA2A P08913 1/20 0.52
ADORA3 P0DMS8 1/20 0.52
TSHR P16473 1/20 0.52
ALOX12 P18054 1/20 0.52
ADRA2B P18089 1/20 0.52
ADRA2C P18825 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3189755 1.00 HSP90AA1 (0.52) HSP90AA1RAD52EGFRLMNAPLA2G1B
Bromide SCHEMBL5084956 1.00 HSP90AA1 (0.52) HSP90AA1RAD52EGFRLMNAPLA2G1B
Bromide SCHEMBL193063 1.00 HSP90AA1 (0.52) HSP90AA1RAD52EGFRLMNAPLA2G1B
Bromide SCHEMBL5091782 1.00 HSP90AA1 (0.52) HSP90AA1RAD52EGFRLMNAPLA2G1B
Bromide SCHEMBL5087893 1.00 HSP90AA1 (0.52) HSP90AA1RAD52EGFRLMNAPLA2G1B
Bromide SCHEMBL574727 1.00 HSP90AA1 (0.52) HSP90AA1RAD52EGFRLMNAPLA2G1B
Bromide SCHEMBL5091686 1.00 HSP90AA1 (0.52) HSP90AA1RAD52EGFRLMNAPLA2G1B
Bromide SCHEMBL28475500 1.00 HSP90AA1 (0.52) HSP90AA1RAD52EGFRLMNAPLA2G1B
Bromide SCHEMBL5087802 1.00 HSP90AA1 (0.52) HSP90AA1RAD52EGFRLMNAPLA2G1B
Bromide SCHEMBL2890412 1.00 HSP90AA1 (0.52) HSP90AA1RAD52EGFRLMNAPLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 319 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188048-A1 METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND JIANGSU CELLURANICS NEW MATERIAL TECHNOLOGY CO., LTD. (CN) 2025-06-12 US claimed
CN-119700885-A Veterinary traditional Chinese medicine granule for preventing and treating atypical bursa of Fabricius of poultry and application thereof 石家庄市九洲兽药有限公司 2025-03-28 CN claimed
CN-119505483-A Epoxy resin composite material and application thereof 内蒙古赛勒商贸有限公司 2025-02-25 CN claimed
CN-119504596-A Preparation method and application of functional lithium battery anode AT9 coating additive material 安徽得壹能源科技有限公司 2025-02-25 CN claimed
EP-4477651-A1 METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND Jiangsu Celluranics New Material Technology Co., Ltd. (CN) 2024-12-18 EP claimed
CN-114941164-A Preparation method of novel difunctional composite coating on surface of magnesium alloy 河南大学 2022-08-26 CN claimed
CN-110196111-B Preparation method of flexible temperature sensor containing ionic liquid 哈尔滨工程大学 2022-06-14 CN claimed
CN-110160646-B Preparation method of MXene-containing flexible near-infrared detector 哈尔滨工程大学 2021-11-09 CN claimed
CN-109001930-B Electric response infrared reflection device and preparation method thereof 华南师范大学 2021-11-02 CN claimed
CN-113117747-A Interfacial ionic liquid supported catalyst for synthesizing cyclic carbonate from carbon dioxide 吉林大学 2021-07-16 CN claimed
EP-2089414-B1 USE OF IONIC LIQUIDS FOR MEMBRANE PROTEIN EXTRACTION MERCK PATENT GMBH (DE) 2013-03-06 EP claimed
US-8143381-B2 Use of ionic liquids for membrane protein extraction MERCK PATENT GMBH (DE) 2012-03-27 US claimed
US-20120052572-A1 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES EXACT SCIENCES CORPORATION 2012-03-01 US claimed
WO-2012018639-A2 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN SALIVA AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES BIOMATRICA, INC. (US) 2012-02-09 WO claimed
WO-2012018638-A2 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES BIOMATRICA, INC. (US) 2012-02-09 WO claimed
US-8071080-B2 May be imidazolium, pyrazolium, pyridinium, pyrimidinium or tetraalkylphosphonium salts; washing (cleaning) and/or conditioning keratin materials, and especially the hair. L'OREAL (FR) 2011-12-06 US claimed
EP-1362572-B2 Use of at least one particular organic salt for cleansing and/or conditioning keratinous materials, use of a particular organic salt as conditioning agent for said materials and process for cosmetic treatment OREAL (FR) 2011-08-17 EP claimed
US-20100029917-A1 USE OF IONIC LIQUIDS FOR MEMBRANE PROTEIN EXTRACTION MERCK PATENT GMBH (DE) 2010-02-04 US claimed
EP-1362572-B1 Use of at least one particular organic salt for cleansing and/or conditioning keratinous materials, use of a particular organic salt as conditioning agent for said materials and process for cosmetic treatment OREAL (FR) 2008-04-16 EP claimed
US-20040005286-A1 Organic salt conditioner, organic salt-containing composition, and uses thereof L'OREAL (FR) 2004-01-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040005286-A1 Organic salt conditioner, organic salt-containing composition, and uses thereof KRT18, HCN4, PRKDC CHRM2 3434/4885CHRM4 2586/4885CHRM5 2069/4885
US-20100029917-A1 USE OF IONIC LIQUIDS FOR MEMBRANE PROTEIN EXTRACTION APMAP, VAMP8, VAMP7 CHRM2 4047/4885CHRM4 3993/4885CHRM5 3128/4885
US-20250188048-A1 METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND HPD, DPYD, PGD CHRM2 3380/4885CHRM4 2985/4885CHRM5 1730/4885
US-20120052572-A1 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES HNRNPD, HNRNPDL, HNRNPL CHRM2 4853/4885CHRM4 4858/4885CHRM5 4842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.